Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G/A for Dynavax Technologies Corporation Common Stock, $0.001 par value (DVAX).
- Disclosed ownership: 0%.
- Date of event: 10 Feb 2026.
Deep Track Capital, LP - 10 Feb 2026 SCHEDULE 13G/A Report for Dynavax Technologies Corporation Common Stock, $0.001 par value (DVAX)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- DVAX
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 Feb 2026, 16:09:56 UTC
- Date of event
- 10 Feb 2026
- Previous filing
- 25 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 0% ownership in Dynavax Technologies Corporation Common Stock, $0.001 par value (DVAX) on 10 Feb 2026."
What Changed
- Previous schedule filing date: 25 Aug 2025.
- Current filing was accepted on 11 Feb 2026, 16:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 0% | 0 | 0 | 0 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 0% | 0 | 0 | 0 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 0% | 0 | 0 | 0 | /s/ David Kroin | David Kroin |